The opinion in support of the decision being entered today is not binding precedent of the Board. UNITED STATES PATENT AND TRADEMARK OFFICE __________ BEFORE THE BOARD OF PATENT APPEALS AND INTERFERENCES __________ Ex parte RAJIV JANJIKHEL, PHILIP IZEVBEHAI, MAHENDRA G. DEDHIYA, and CHARLES LINDAMOOD III __________ Appeal 2007-3734 Application 11/286,137 Technology Center 1600 __________ Decided: September 25, 2007 __________ Before TONI R. SCHEINER, DONALD E. ADAMS, and ERIC GRIMES, Administrative Patent Judges. GRIMES, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134 involving claims to a pharmaceutical composition. The Examiner has rejected the claims as obvious. We have jurisdiction under 35 U.S.C. § 6(b). We affirm. BACKGROUND The Specification describes “a pharmaceutical formulation comprising ibuprofen . . . , oxycodone . . . , and 14-hydroxycodeinone . . . , and its use for the treatment of pain” (Specification 2). The Specification states that thePage: 1 2 3 4 5 6 7 Next
Last modified: September 9, 2013